Filing Details

Accession Number:
0001209191-20-047352
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-18 20:16:09
Reporting Period:
2020-08-18
Accepted Time:
2020-08-18 20:16:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1290149 Sierra Oncology Inc. SRRA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647647 Barbara Klencke C/O Sierra Oncology, Inc.
2150 885 West Georgia St.
Vancouver A1 V6C 3E8
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-18 5,950 $12.22 10,000 No 4 P Direct
Common Stock Acquisiton 2020-08-18 3,325 $12.25 5,000 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By spouse
Footnotes
  1. Represents the weighted average purchase price. The lowest price at which shares were purchased was $12.21 and the highest price at which shares were purchased was $12.23. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
  2. Represents the weighted average purchase price. The lowest price at which shares were purchased was $12.22 and the highest price at which shares were purchased was $12.30.